课题基金 / 基金详情

FER as a novel therapeutic target in breast cancer

FER as a novel therapeutic target in breast cancer
FER 作为乳腺癌的新治疗靶点
批准号：
368652
负责人：
Greer Peter A
金额：
$69.94万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=368652&lang=en
关键词：
Breast Cancer Inhibitors Metastasis Preclinical Models Protein Tyrosine Kinases Signal Transduction

项目摘要

项目成果

Greer Peter A的其他基金

相似基金

相关文献

中文摘要
翻译
癌症是由控制细胞增殖和存活的基因表达失调引起的复杂连续疾病。不幸的是，许多基因都可能参与其中，这就解释了为什么癌症在临床行为和反应上如此多样化
英文摘要
Cancer is a complex continuum of diseases caused by dysregulated expression of the genes controlling cell proliferation and survival. Unfortunately, many genes can be involved, which explains why cancers are so diverse in clinical behaviour and response t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the calpain protease in breast cancer
Development of a biosensor for high throughput screening of novel compounds targeting ezrin for breast cancer therapy
Calpain as a novel therapeutic target in breast cancer
FER as a novel therapeutic target in breast cancer
海外基金